PCV49 COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PORTUGUESE PATIENTS
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.774
https://www.valueinhealthjournal.com/article/S1098-3015(19)33152-3/fulltext
Title :
PCV49 COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PORTUGUESE PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33152-3&doi=10.1016/j.jval.2019.09.774
First page :
Section Title :
Open access? :
No
Section Order :
10672